Annexon (ANNX) Change in Account Payables (2019 - 2026)
Annexon's (ANNX) quarterly Change in Account Payables came in at $2.2 million in Q1 2026, up 7038.71% year-on-year from $30131.5 in Q1 2025, and up 165.88% quarter-over-quarter from -$3.3 million in Q4 2025.
Annexon (ANNX) Change in Account Payables (2019 - 2026) Analysis & Trends
Annexon's Change in Account Payables history runs 8 years deep, the most recent figure standing at $2.2 million for Q1 2026.
- On a quarterly basis, Change in Account Payables rose 7038.71% year-over-year to $2.2 million in Q1 2026; TTM through Mar 2026 was $6.7 million, a 3.68% increase from a year earlier, with the FY2025 full-year figure at $4.5 million, down 9.02% from the prior year.
- Change in Account Payables rose to $2.2 million in Q1 2026 per ANNX's latest filing, from -$3.3 million in the prior quarter.
- Across five years, Change in Account Payables topped out at $6.7 million in Q3 2025 and bottomed at -$3.4 million in Q3 2022.
- The 5-year median for Change in Account Payables is $490000.0 (2022), against an average of $542000.0.
- Across the five-year window, Change in Account Payables plunged 514.18% in 2022 and soared 7038.71% in 2026, its largest moves.
- Year by year, Change in Account Payables stood at $490000.0 in 2022, then dropped by 13.06% to $426000.0 in 2023, then surged by 765.96% to $3.7 million in 2024, then tumbled by 188.51% to -$3.3 million in 2025, then surged by 165.88% to $2.2 million in 2026.
- Per Business Quant, the three latest ANNX Change in Account Payables figures stand at $2.2 million (Q1 2026), -$3.3 million (Q4 2025), and $6.7 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Account Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | -42.19 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | -1.52 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 35.60 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 16.86 Mn |
| 10 | Annexon | 1.03 Bn | 804.24 Mn | - | 2.15 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.15 Mn |
| Mar 31, 2026 | 2.15 Mn |
| Dec 31, 2025 | -3.27 Mn |
| Dec 31, 2025 | -3.27 Mn |
| Sep 30, 2025 | 6.67 Mn |
| Sep 30, 2025 | 6.67 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Jun 30, 2025 | 1.12 Mn |
| Mar 31, 2025 | -31,000.00 |
| Mar 31, 2025 | -31,000.00 |
| Dec 31, 2024 | 3.69 Mn |
| Dec 31, 2024 | 3.69 Mn |
| Sep 30, 2024 | 2.70 Mn |
| Sep 30, 2024 | 2.70 Mn |
| Jun 30, 2024 | 74,000.00 |
| Jun 30, 2024 | 74,000.00 |
| Mar 31, 2024 | -1.53 Mn |
| Mar 31, 2024 | -1.53 Mn |
| Dec 31, 2023 | 426,000.00 |
| Dec 31, 2023 | 426,000.00 |